Skip to content

The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer

Thyroid Cancer | Thyroid Nodule

The goal of this clinical trial is to test radiofrequency ablation (RFA) in thyroid cancers ≤2 cm in diameter. The main question it aims to answer is:

• What is the feasibility of RFA use for low-risk thyroid cancers (≤2 cm)?

Participants will undergo a set of pre-procedural scans of the target thyroid nodule and undergo the RFA procedure/intervention. Then, participants will partake in three follow-up appointments at 4 weeks, 6 months, and 12 months post-procedure as per standard of care.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:

1\. Patients with:

* Nodule less than or equal to 2cm in size

a. Specifically: Bethesda 5/6
* Their age is ≥18 years and ≤100 years
* Able to provide written consent
* Able to attend required follow-ups as per the protocol

Exclusion Criteria:

* Patients \<18 years old
* Pregnant women
* Any concern for invasive or metastatic thyroid cancer
* Previously treated for thyroid cancer

Lieu de l'étude

University Health Network
University Health Network
Toronto, Ontario
Canada

Contactez l'équipe d'étude

Primary Contact

Ilhaan Abdulle

[email protected]
(416) 340-4792
Backup Contact

Emily Saso

[email protected]
(613) 854-4420
Étude parrainée par
University Health Network, Toronto
Participants recherchés
Plus d'informations
ID de l'étude: NCT06929650